• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    12/21/23 1:01:44 PM ET
    $ACON
    $AHCO
    $ANNX
    $ATAK
    Medical Specialities
    Health Care
    Medical/Nursing Services
    Health Care
    Get the next $ACON alert in real time by email

    Shares of CarMax, Inc. (NYSE:KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

    KMX reported a third-quarter sales decline of 5.5% year-on-year to $6.15 billion, missing the analyst consensus estimate of $6.33 billion. EPS of $0.52 beat the consensus estimate of $0.44.

    CarMax shares climbed 7.7% to $80.42 on Thursday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Infrared Cameras Holdings Inc (NASDAQ:MSAI) shares jumped 222% to $8.43 after falling over 61% on Wednesday.
    • HOOKIPA Pharma Inc. (NASDAQ:HOOK) surged 75% to $0.9874 after the company announced a $21.25 million equity investment from Gilead Sciences.
    • DMK Pharmaceuticals Corporation (NASDAQ:DMK) shares climbed 50.8% to $0.8899. DMK Pharmaceuticals regained full rights to commercialize ZIMHI after the termination of an exclusive commercialization and distribution with US WorldMeds, LLC.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) shares rose 41.3% to $1.20.
    • ParaZero Technologies Ltd. (NASDAQ:PRZO) shares climbed 37.4% to $1.6904 after the company appointed Nir Ben Moshe, a former senior director in the Israeli Ministry of Defense, as a specialist advisor.
    • Annexon, Inc. (NASDAQ:ANNX) gained 34.7% to $3.88. Annexon outlined its global registrational program for ANX007 for the treatment of patients with geographic atrophy. The company also reported pricing of $125 million public offering of common stock.
    • Triumph Group, Inc. (NYSE:TGI) rose 27% to $15.59 after the company entered into a definitive agreement with AAR to sell its Product Support business.
    • Aurora Technology Acquisition Corp.. (NASDAQ:ATAK) shares gained 26.3% to $5.57 after falling 15% on Wednesday.
    • Galiano Gold Inc. (NYSE:GAU) rose 23.5% to $0.8130 as the company announced that it has entered into a binding share purchase agreement with subsidiaries of Gold Fields Limited.
    • Calliditas Therapeutics AB (NASDAQ:CALT) gained 19.3% to $26.37 after the company announced FDA approval of TARPEYO.
    • Iris Energy Limited (NASDAQ:IREN) gained 19.2% to $6.59. Iris energy disclosed that its 10 EH/s expansion is fully funded following completion of targeted equity raising program.
    • MeiraGTx Holdings plc (NASDAQ:MGTX) rose 19.1% to $5.85 after the company announced an asset purchase agreement involving its AAV-RPGR collaboration for up to $415 million.
    • Shengfeng Development Limited (NASDAQ:SFWL) rose 17.6% to $4.27.
    • AdaptHealth Corp. (NASDAQ:AHCO) gained 11.6% to $7.24
    • Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) gained 11.4% to $15.93. Oppenheimer initiated coverage on Catalyst Pharmaceuticals with an Outperform rating and announced a price target of $30.
    • Grupo Supervielle S.A. (NYSE:SUPV) gained 10.8% to $4.58.
    • Energy Fuels Inc. (NYSE:UUUU) rose 10.3% to $7.68. Energy Fuels disclosed the commencement of uranium production at three of its permitted and developed mines in Arizona and Utah and preparing two additional mines in Colorado and Wyoming for expected production within one year.
    • Cytokinetics, Incorporated (NASDAQ:CYTK) rose 9.7% to $39.19.
    • Immunovant, Inc. (NASDAQ:IMVT) shares gained 9.4% to $39.61 after reporting initial Phase 2 results for Batoclimab in Graves’ disease.
    • 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) surged 8.6% to $20.69. 4D Molecular Therapeutics announced that the FDA granted the RMAT designation for the investigational genetic medicine candidate 4D-150 for intravitreal treatment of wet age-related macular degeneration.
    • Globalstar, Inc. (NYSE:GSAT) gained 8.2% to $1.8500. Globalstar Director James F Lynch acquired a total of 750,000 shares at an average price of $1.69.
    • Micron Technology, Inc. (NASDAQ:MU) rose 7.5% to $84.57 after the company reported mixed first-quarter financial results and issued strong guidance.
    • 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares gained 6.8% to $1.25 after jumping 36% on Wednesday.
    • Canaan Inc. (NASDAQ:CAN) shares rose 5.1% to $2.70 amid strength in Bitcoin.

    Losers

    • Nogin, Inc. (NASDAQ:NOGN) shares fell 42.6% to $0.0644 after dipping over 30% on Wednesday.
    • Polished.com Inc. (NYSE:POL) shares fell 40.9% to $4.50 after jumping 618% on Wednesday.
    • BYTE Acquisition Corp. (NASDAQ:BYTS) dipped 38% to $6.49.
    • Clene Inc. (NASDAQ:CLNN) fell 36.7% to $0.3260. Clene reported new data from 12-month long-term open label extension of CNM-Au8 treatment arm in HEALEY ALS platform trial.
    • Revelstone Capital Acquisition Corp. (NASDAQ:RCAC) fell 37% to $6.80.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 25.2% to $0.8971. Panbela Therapeutics entered into agreements with certain stockholders for $2 million private placement of existing warrants exercisable for 2,556,000 of its common stock, in aggregate, to exercise outstanding warrants at $0.78 per share in exchange for new warrants.
    • Longeveron Inc. (NASDAQ:LGVN) fell 24% to $1.23 after the company announced a $2.36 million registered direct offering priced at-the-market under Nasdaq rules.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 22.3% to $0.0091. Esports Entertainment shares fell 41% on Wednesday after the company announced a 1-for-400 reverse stock split.
    • Aclarion, Inc. (NASDAQ:ACON) shares fell 21.5% to $0.2739. Aclarion shares rose over 19% on Wednesday after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS (Severe Low Back Pain)."
    • MedAvail Holdings, Inc. (NASDAQ:MDVL) fell 20% to $4.76.
    • Genetic Technologies Limited (NASDAQ:GENE) dipped 16.2% to $2.12.
    • Jin Medical International Ltd. (NASDAQ:ZJYL) tumbled 14.3% to $71.62. On Dec 18, Jin Medical International received Nasdaq letter notifying that the company failed to give detailed plan to support decision for further time for compliance.
    • Ispire Technology Inc. (NASDAQ:ISPR) fell 14.1% to $11.78.
    • BlackBerry Limited (NYSE:BB) fell 12.3% to $3.5950 following the release of third-quarter results.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) declined 10.7% to $24.78.
    • Dune Acquisition Corporation (NASDAQ:DUNE) fell 10.4% to $4.1382 after gaining 6% on Wednesday.
    • iCoreConnect Inc. (NASDAQ:ICCT) shares fell 10.2% to $1.5350.

     

    Now Read This: How To Earn $500 A Month From Broadcom Stock Following Recent Rally

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $AHCO
    $ANNX
    $ATAK

    CompanyDatePrice TargetRatingAnalyst
    Micron Technology Inc.
    $MU
    3/19/2026Buy → Hold
    Summit Insights
    Micron Technology Inc.
    $MU
    3/19/2026$450.00 → $500.00Buy
    Needham
    Micron Technology Inc.
    $MU
    2/17/2026$380.00 → $450.00Buy
    Needham
    Energy Fuels Inc
    $UUUU
    2/11/2026$30.00Buy
    Goldman
    Cytokinetics Incorporated
    $CYTK
    1/28/2026$87.00Overweight
    Barclays
    4D Molecular Therapeutics Inc.
    $FDMT
    1/28/2026$33.00Overweight
    Barclays
    Energy Fuels Inc
    $UUUU
    1/28/2026$15.50Sell → Neutral
    Roth Capital
    Micron Technology Inc.
    $MU
    1/23/2026$350.00 → $500.00Buy
    HSBC Securities
    More analyst ratings

    $ACON
    $AHCO
    $ANNX
    $ATAK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Micron downgraded by Summit Insights

    Summit Insights downgraded Micron from Buy to Hold

    3/19/26 8:25:02 AM ET
    $MU
    Semiconductors
    Technology

    Needham reiterated coverage on Micron with a new price target

    Needham reiterated coverage of Micron with a rating of Buy and set a new price target of $500.00 from $450.00 previously

    3/19/26 7:49:58 AM ET
    $MU
    Semiconductors
    Technology

    Needham reiterated coverage on Micron with a new price target

    Needham reiterated coverage of Micron with a rating of Buy and set a new price target of $450.00 from $380.00 previously

    2/17/26 7:06:48 AM ET
    $MU
    Semiconductors
    Technology

    $ACON
    $AHCO
    $ANNX
    $ATAK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Autonomous Warfare Takes Flight: Military Drone Market Set for Explosive Growth Through 2030

    Surging demand for UAVs, counter-drone systems, and AI-driven battlefield intelligence is driving multi-billion-dollar growth across global defense sectors through 2030NEW YORK, March 19, 2026 /CNW/ -- Market News Updates News Commentary -- The global drone and defense landscape is no longer emerging--it's accelerating at a pace that's forcing governments and contractors to rethink modern warfare in real time. From tactical ISR missions to fully autonomous swarm deployments, unmanned systems are becoming central to national security strategies worldwide. According to industry data, the broader UAV market is projected to surge to approximately $102.7 billion by 2030, expanding at a double-dig

    3/19/26 9:50:00 AM ET
    $AGH
    $DPRO
    $PRZO
    Hotels/Resorts
    Consumer Discretionary
    Aerospace
    Industrials

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

    Pursuing reimbursement coverage from one or more regional insurance providers in the United States as an important step toward broader payer adoption Initial CLARITY trial readout in Q4 2026 Strong Balance Sheet with Cash Runway into 2028 BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the publication of a Shareholder Letter from Chief Executive Officer Brent Ness providing an update on the company's

    3/19/26 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AHCO
    $ANNX
    $ATAK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Arcucci Bruno Jesus

    3 - Grupo Supervielle S.A. (0001517399) (Issuer)

    3/18/26 6:28:28 PM ET
    $SUPV
    Commercial Banks
    Finance

    SEC Form 4 filed by Blum Robert I

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    3/18/26 5:37:21 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Malik Fady Ibraham

    4 - CYTOKINETICS INC (0001061983) (Issuer)

    3/18/26 5:40:44 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AHCO
    $ANNX
    $ATAK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TARPEYO issued to CALLIDITAS THERAPEUTICS AB

    Submission status for CALLIDITAS THERAPEUTICS AB's drug TARPEYO (ORIG-1) with active ingredient BUDESONIDE has changed to 'Approval' on 12/15/2021. Application Category: NDA, Application Number: 215935, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/20/21 3:40:41 PM ET
    $CALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AHCO
    $ANNX
    $ATAK
    SEC Filings

    View All

    SEC Form 8-K filed by Catalyst Pharmaceuticals Inc.

    8-K - CATALYST PHARMACEUTICALS, INC. (0001369568) (Filer)

    3/18/26 5:14:50 PM ET
    $CPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Energy Fuels Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - ENERGY FUELS INC (0001385849) (Filer)

    3/18/26 5:11:25 PM ET
    $UUUU
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    SEC Form 10-K filed by Aclarion Inc.

    10-K - Aclarion, Inc. (0001635077) (Filer)

    3/18/26 4:57:42 PM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AHCO
    $ANNX
    $ATAK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner A.L. Sarroff Fund, Llc bought 1,250,000 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    3/13/26 5:10:25 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Large owner Cashin Richard M Jr bought $19,912,148 worth of shares (2,046,691 units at $9.73) (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    3/12/26 9:11:41 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Director Carson William H. bought $45,360 worth of shares (8,000 units at $5.67), increasing direct ownership by 15% to 62,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/12/26 4:31:34 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AHCO
    $ANNX
    $ATAK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

    SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

    11/19/24 3:38:53 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $ACON
    $AHCO
    $ANNX
    $ATAK
    Financials

    Live finance-specific insights

    View All

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    Micron Technology, Inc. Reports Results for the Second Quarter of Fiscal 2026

    BOISE, Idaho, March 18, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ:MU) today announced results for its second quarter of fiscal 2026, which ended February 26, 2026. Fiscal Q2 2026 highlights Revenue of $23.86 billion versus $13.64 billion for the prior quarter and $8.05 billion for the same period last yearGAAP net income of $13.79 billion, or $12.07 per diluted shareNon-GAAP net income of $14.02 billion, or $12.20 per diluted shareOperating cash flow of $11.90 billion versus $8.41 billion for the prior quarter and $3.94 billion for the same period last year "Micron set new records across revenue, gross margin, EPS, and free cash flow in fiscal Q2, driven by a strong dem

    3/18/26 4:01:00 PM ET
    $MU
    Semiconductors
    Technology

    Longeveron Announces 2025 Full Year Financial Results and Provides Business Update

    On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indicationELPIS II may serve as foundation for a Biologics License Application (BLA) submission for full approval for HLHS, if results demonstrate sufficient evidence of efficacyClosed a private placement of up to $30 million, with $15 million funded in the initial closing, led by Coastlands Capital with participation from Janus Henderson Investors and other healthcare focused fundsCompany to host conference call and webcast today at 4:30 p.m. ET MIAMI, March 17

    3/17/26 4:05:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AHCO
    $ANNX
    $ATAK
    Leadership Updates

    Live Leadership Updates

    View All

    Starboard Delivers Letter to CarMax

    Views Appointment of New CEO Keith Barr as Timely Opportunity to Address Fixable Execution Gaps and Unlock CarMax's Full Value Potential Has Nominated Directors to Help Support the Next Phase of Execution and Accelerate Shareholder Value Creation Believes CarMax's Structurally Superior Omnichannel Model Is Not Reflected in Current Performance Sees Clear Opportunities to Drive Improvement Through Enhanced Digital Execution, Reconditioning Efficiencies and Dynamic Pricing Urges a Substantially Expanded SG&A Reduction Program to Restore Cost Discipline and Enhance Long-Term Earnings Power Starboard Value LP (together with its affiliates, "Starboard"), a significant stockholder of Car

    3/11/26 8:00:00 AM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials